Graham Capital Management, L.P. Ardelyx, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 42,531 shares of ARDX stock, worth $259,439. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,531
Previous 19,884
113.9%
Holding current value
$259,439
Previous $145,000
117.24%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$158 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$83.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$73 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$42.1 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $943M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...